Overview

APL93: Timing of CxT and Role of Maintenance

Status:
Completed
Trial end date:
1998-12-01
Target enrollment:
Participant gender:
Summary
Objectives of the trial were to assess the optimal timing of chemotherapy with or after ATRA and the role of maintenance therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Collaborator:
DRC lille, France
Treatments:
6-Mercaptopurine
Methotrexate
Tretinoin